Exact Mass: 469.3012524

Exact Mass Matches: 469.3012524

Found 28 metabolites which its exact mass value is equals to given mass value 469.3012524, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Neomethymycin

C25H43NO7 (469.30393680000003)

A twelve-membered macrolide antibiotic that is biosynthesised by Streptomyces venezuelae.

Methymycin

C25H43NO7 (469.30393680000003)

A twelve-membered macrolide antibiotic that is biosynthesised by Streptomyces venezuelae.

ebastine

C32H39NO2 (469.2980634)

R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Ebastine (LAS-W 090) is an orally active, second-generation histamine H1 receptor antagonist. Ebastine can be used for the symptoms of allergic rhinitis and chronic idiopathic urticaria research[1].

Ebastine

1-[4-(1,1-Dimethylethyl)phenyl]-4-[4-(diphenylmethoxy)-1-piperidinyl]-1-butanone

C32H39NO2 (469.2980634)

Ebastine (trade names Evastin, Kestine, Ebastel, Aleva) is a non-sedating H1 antihistamine. It does not penetrate the blood–brain barrier and thus allows an effective block of the H1 receptor in peripheral tissue without a central side effect, i. e not causing sedation or drowsiness. The basic patent for ebastine in Europe is EP-B-134124. It is often provided in micronised form, due to poor water solubility. (Wikipedia) CYP2J2, an arachidonic acid epoxygenase, is recognized for its role in the first-pass metabolism of astemizole and ebastine. (PMID: 22328583) R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Ebastine (LAS-W 090) is an orally active, second-generation histamine H1 receptor antagonist. Ebastine can be used for the symptoms of allergic rhinitis and chronic idiopathic urticaria research[1].

Eflucimibe

2-(dodecylsulfanyl)-N-(4-hydroxy-2,3,5-trimethylphenyl)-2-phenylacetamide

C29H43NO2S (469.30143380000004)

tumonoic acid G

C25H43NO7 (469.30393680000003)

A natural product found particularly in Oscillatoria margaritifera and Oscillatoria margaritifera.

Ebastin

ebastine

C32H39NO2 (469.2980634)

R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist CONFIDENCE standard compound; INTERNAL_ID 2512 COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 8493 Ebastine (LAS-W 090) is an orally active, second-generation histamine H1 receptor antagonist. Ebastine can be used for the symptoms of allergic rhinitis and chronic idiopathic urticaria research[1].

Pro Arg Val Val

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-methylbutanamido]-3-methylbutanoic acid

C21H39N7O5 (469.3012524)

Pro Val Arg Val

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]pentanamido]-3-methylbutanoic acid

C21H39N7O5 (469.3012524)

Pro Val Val Arg

(2S)-5-carbamimidamido-2-[(2S)-3-methyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanamido]pentanoic acid

C21H39N7O5 (469.3012524)

Arg Pro Val Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-methylbutanoic acid

C21H39N7O5 (469.3012524)

Arg Val Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C21H39N7O5 (469.3012524)

Arg Val Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C21H39N7O5 (469.3012524)

Val Pro Arg Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C21H39N7O5 (469.3012524)

Val Pro Val Arg

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C21H39N7O5 (469.3012524)

Val Arg Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C21H39N7O5 (469.3012524)

Val Arg Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C21H39N7O5 (469.3012524)

Val Val Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C21H39N7O5 (469.3012524)

Val Val Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C21H39N7O5 (469.3012524)

2-[[4-[2-[4-(oxiran-2-ylmethoxy)phenyl]propan-2-yl]phenoxy]methyl]oxirane,2-piperazin-1-ylethanamine

C27H39N3O4 (469.2940414)

4-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-12-(1-hydroxyethyl)-3,5,7,11-tetramethyl-1-oxacyclododec-9-ene-2,8-dione

C25H43NO7 (469.30393680000003)

2-{[(2r,3s)-3-methyl-2-[(2s)-1-[(2s)-2-methyldecanoyl]pyrrolidine-2-carbonyloxy]pentanoyl]oxy}propanoic acid

C25H43NO7 (469.30393680000003)

2-({3-methyl-2-[1-(2-methyldecanoyl)pyrrolidine-2-carbonyloxy]pentanoyl}oxy)propanoic acid

C25H43NO7 (469.30393680000003)

4-[(1e)-3-({4-[(3-aminopropyl)amino]butyl}[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-yl]amino)prop-1-en-1-yl]-2-methoxyphenol

C27H39N3O4 (469.2940414)

4-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-12-ethyl-11-hydroxy-3,5,7,11-tetramethyl-1-oxacyclododec-9-ene-2,8-dione

C25H43NO7 (469.30393680000003)